Randomized, Double-Blind, Placebo-Controlled Pilot Study on the Safety and Effectiveness of LUCEMYRA During an Opioid Taper in Treatment of Withdrawal

NCT04070157 · clinicaltrials.gov ↗
PHASE2
Phase
TERMINATED
Status
4
Enrollment
INDUSTRY
Sponsor class

Stopped COVID pandemic and enrollment issues necessitating an adjustment to the study design.

Conditions

Interventions

Sponsor

USWM, LLC (dba US WorldMeds)